Related Experiment Video
Updated: Apr 22, 2026
06:15
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
1.7K
Primary liposarcoma of the orbit
Saurbhi Khurana, Anoop K Gupta, Seema Sen
1Department of Ocular Pathology, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Indian Journal of Pathology & Microbiology
|October 14, 2014
Summary
Orbital liposarcoma, a rare cancer, was treated in four adult patients. Surgical removal and radiation therapy led to no recurrence over a 1-5 year follow-up, indicating effective treatment for this rare orbital tumor.
Area of Science:
- Ophthalmology
- Oncology
- Pathology
Background:
- Liposarcoma is the most common soft tissue sarcoma in adults.
- Orbital liposarcoma is an exceptionally rare diagnosis.
- Understanding the behavior of rare orbital tumors is crucial for effective management.
Observation:
- Four cases of primary orbital liposarcoma were identified and treated.
- All tumors were confined to the orbital region.
- Treatment involved surgical excision (exenteration) with adjuvant radiotherapy in one case.
Findings:
- No recurrence was observed in any of the four patients.
- Follow-up ranged from 1 to 5 years, with a mean of 4 years.
- Complete resection and adjuvant therapy appear to yield favorable outcomes.
Implications:
- This case series suggests that orbital liposarcoma, despite its rarity, can be managed effectively.
- Prompt diagnosis and aggressive treatment, including surgery and potentially radiotherapy, are key.
- Further research into the specific characteristics and optimal management of orbital liposarcoma is warranted.
